Noida
08048037449
+917827977911

Diabetes Type 2 - Causes, Treatment and Management

What is Type 2 Diabetes?

Type 2 Diabetes is a chronic metabolic disorder characterized by persistent high blood glucose (hyperglycemia) resulting from:

  • Insulin resistance – the body's cells do not respond effectively to insulin.
  • Progressive pancreatic β-cell dysfunction – the pancreas gradually loses its ability to produce sufficient insulin.

Unlike Type 1 Diabetes, where insulin production is severely reduced due to autoimmune destruction of β-cells, patients with Type 2 Diabetes usually continue to produce insulin, especially in the early stages, but it is insufficient to overcome insulin resistance.


Normal Glucose Metabolism

Under normal conditions:

  1. Food is digested into glucose.
  2. Blood glucose rises.
  3. The pancreas releases insulin.
  4. Insulin binds to receptors on muscle, liver, and fat cells.
  5. Glucose enters cells and is used for energy or stored as glycogen.
  6. Blood glucose returns to normal.

What Happens in Type 2 Diabetes?

1. Insulin Resistance

The body's cells become less responsive to insulin.

As a result:

  • Less glucose enters muscle and fat cells.
  • The liver continues producing glucose even when it is not needed.
  • Blood glucose remains elevated.

Initially, the pancreas compensates by producing more insulin (hyperinsulinemia).


2. Progressive β-cell Dysfunction

Over time:

  • Pancreatic β-cells become exhausted.
  • Insulin secretion declines.
  • Blood glucose levels continue to rise.

Eventually, many patients require insulin therapy because endogenous insulin production becomes inadequate.


Major Causes of Type 2 Diabetes

Type 2 Diabetes develops due to a combination of genetic susceptibility and environmental/lifestyle factors.

1. Genetics

  • Family history significantly increases risk.
  • Multiple genes influence insulin secretion and insulin sensitivity.
  • Risk is higher if one or both parents have diabetes.

2. Obesity (Most Important Modifiable Risk Factor)

Excess body fat, particularly visceral (abdominal) fat, promotes insulin resistance.

Fat tissue releases:

  • Free fatty acids
  • Pro-inflammatory cytokines
  • Adipokines

These interfere with insulin signaling.


3. Physical Inactivity

Lack of exercise leads to:

  • Reduced glucose uptake by muscles
  • Increased insulin resistance
  • Weight gain

Regular physical activity improves insulin sensitivity.


4. Unhealthy Diet

High intake of:

  • Refined carbohydrates
  • Sugary beverages
  • Processed foods
  • Saturated and trans fats

contributes to:

  • Weight gain
  • Chronic inflammation
  • Insulin resistance

5. Aging

Risk increases after 45 years, although Type 2 Diabetes is becoming increasingly common in younger adults and adolescents due to rising obesity rates.


6. Metabolic Syndrome

People with:

  • Central obesity
  • High blood pressure
  • Elevated triglycerides
  • Low HDL cholesterol
  • Insulin resistance

have a markedly increased risk of developing Type 2 Diabetes.


7. Hormonal Disorders

Certain conditions increase insulin resistance, including:

  • Polycystic Ovary Syndrome
  • Cushing syndrome
  • Acromegaly

8. Certain Medications

Long-term use of some drugs may increase diabetes risk, such as:

  • Corticosteroids
  • Some antipsychotics
  • Certain immunosuppressants

9. Smoking

Smoking:

  • Increases systemic inflammation
  • Promotes insulin resistance
  • Raises the risk of cardiovascular complications

10. Chronic Stress and Poor Sleep

These factors increase stress hormones (e.g., cortisol), which:

  • Increase blood glucose
  • Worsen insulin resistance
  • Promote weight gain

Common Symptoms

  • Increased thirst (polydipsia)
  • Frequent urination (polyuria)
  • Increased hunger (polyphagia)
  • Fatigue
  • Blurred vision
  • Slow wound healing
  • Recurrent infections
  • Unexplained weight loss (in advanced disease)
  • Numbness or tingling in the hands and feet

Complications (If Untreated)

Microvascular complications

  • Diabetic retinopathy
  • Diabetic nephropathy
  • Diabetic neuropathy

Macrovascular complications

  • Coronary artery disease
  • Stroke
  • Peripheral artery disease

Key Takeaway

Type 2 Diabetes is a progressive metabolic disease caused by the combined effects of insulin resistance and declining pancreatic β-cell function. While genetics influence susceptibility, major modifiable contributors include obesity, physical inactivity, unhealthy diet, smoking, and chronic stress. Early diagnosis and lifestyle changes, along with appropriate medication when needed, can help control blood glucose and reduce the risk of long-term complications.

Line of Treatment for Type 2 Diabetes Mellitus (T2DM) with Mechanism of Action

The treatment of Type 2 Diabetes follows a stepwise approach aimed at:

  • Achieving glycemic control (HbA1c target usually <7%, individualized)
  • Preventing microvascular and macrovascular complications
  • Reducing cardiovascular and renal risk
  • Preserving pancreatic β-cell function

Step 1: Lifestyle Modification (First-Line Therapy)

Mechanism of Action

Medical Nutrition Therapy

  • Reduces postprandial glucose excursions
  • Decreases calorie intake and body weight
  • Improves insulin sensitivity
  • Reduces hepatic glucose production

Regular Physical Activity

  • Increases GLUT-4 transporter translocation in skeletal muscle
  • Enhances glucose uptake independent of insulin
  • Improves insulin sensitivity
  • Reduces visceral fat

Weight Reduction

  • Decreases inflammatory cytokines
  • Improves insulin receptor signaling
  • Lowers insulin resistance
  • Preserves β-cell function

Step 2: Pharmacological Therapy

1. Metformin (First-Line Drug)

Examples

  • Metformin

Mechanism of Action

✔ Activates AMP-activated protein kinase (AMPK)

Effects:

  • ↓ Hepatic gluconeogenesis
  • ↓ Intestinal glucose absorption
  • ↑ Peripheral insulin sensitivity
  • ↑ Muscle glucose uptake
  • Mild weight loss
  • No hypoglycemia when used alone

Clinical Benefits

  • First-line therapy worldwide
  • HbA1c reduction: 1–1.5%
  • Weight neutral or modest weight loss
  • Cardiovascular benefit
  • Low cost

2. SGLT2 Inhibitors

Examples

  • Empagliflozin
  • Dapagliflozin
  • Canagliflozin

Mechanism of Action

Acts in the proximal renal tubule by:

  • Blocking Sodium-Glucose Co-transporter-2 (SGLT2)
  • Preventing glucose reabsorption
  • Increasing urinary glucose excretion
  • Lowering blood glucose independently of insulin

Additional Benefits

  • Weight loss
  • Blood pressure reduction
  • Cardiovascular protection
  • Renal protection
  • Reduced hospitalization for heart failure

3. GLP-1 Receptor Agonists

Examples

  • Semaglutide
  • Liraglutide
  • Dulaglutide

Mechanism of Action

Mimic endogenous GLP-1 hormone:

  • Increase glucose-dependent insulin secretion
  • Decrease glucagon secretion
  • Delay gastric emptying
  • Increase satiety
  • Reduce appetite

Additional Benefits

  • Significant weight loss
  • Low hypoglycemia risk
  • Cardiovascular protection
  • Improvement in fatty liver disease

4. DPP-4 Inhibitors

Examples

  • Sitagliptin
  • Linagliptin
  • Vildagliptin

Mechanism of Action

  • Inhibit DPP-4 enzyme
  • Prevent degradation of endogenous GLP-1 and GIP
  • Increase insulin secretion
  • Decrease glucagon release

Benefits

  • Weight neutral
  • Low risk of hypoglycemia
  • Well tolerated

5. Sulfonylureas

Examples

  • Glimepiride
  • Gliclazide

Mechanism of Action

  • Close ATP-sensitive potassium channels on pancreatic β-cells
  • Depolarize β-cell membrane
  • Open calcium channels
  • Trigger insulin release

Advantages

  • Rapid glucose lowering
  • Inexpensive

Limitations

  • Hypoglycemia
  • Weight gain

6. Thiazolidinediones (TZDs)

Examples

  • Pioglitazone

Mechanism of Action

Activates PPAR-γ receptors leading to:

  • Improved insulin sensitivity
  • Increased glucose uptake
  • Reduced hepatic glucose production
  • Redistribution of fat away from visceral depots

Benefits

  • Improves insulin resistance
  • Durable HbA1c reduction

Limitations

  • Weight gain
  • Fluid retention
  • Risk of heart failure in susceptible patients

7. Alpha-Glucosidase Inhibitors

Examples

  • Acarbose

Mechanism of Action

  • Inhibit intestinal alpha-glucosidase enzymes
  • Delay carbohydrate digestion
  • Reduce postprandial glucose spikes

8. Meglitinides

Examples

  • Repaglinide

Mechanism of Action

  • Stimulate rapid insulin secretion
  • Particularly effective for post-meal glucose control

9. Insulin Therapy

Indicated when:

  • HbA1c remains uncontrolled despite oral agents
  • Severe hyperglycemia
  • Symptomatic diabetes
  • Acute illness, surgery, or pregnancy

Mechanism of Action

Exogenous insulin:

  • Promotes glucose uptake by muscle and adipose tissue
  • Suppresses hepatic glucose production
  • Inhibits lipolysis
  • Promotes glycogen synthesis
  • Reduces blood glucose

Recommended Treatment Sequence (ADA/EASD-Based)

Stage

Preferred Treatment

Newly diagnosed

Lifestyle modification + Metformin

HbA1c above target

Add SGLT2 inhibitor or GLP-1 receptor agonist (especially if cardiovascular disease, heart failure, chronic kidney disease, or obesity are present)

Further uncontrolled

Triple therapy with complementary drug classes

Persistent uncontrolled or symptomatic hyperglycemia

Initiate basal insulin ± GLP-1 receptor agonist

Advanced disease

Basal-bolus insulin regimen if needed


Summary of Drug Classes and Mechanisms

Drug Class

Primary Mechanism

Major Benefit

Metformin

↓ Hepatic glucose production; ↑ insulin sensitivity

First-line, weight neutral

SGLT2 inhibitors

↑ Urinary glucose excretion

Cardio-renal protection, weight loss

GLP-1 receptor agonists

↑ Insulin, ↓ glucagon, delayed gastric emptying

Weight loss, cardiovascular benefit

DPP-4 inhibitors

↑ Endogenous incretin activity

Weight neutral, low hypoglycemia risk

Sulfonylureas

↑ Pancreatic insulin secretion

Potent glucose lowering, low cost

TZDs

↑ Peripheral insulin sensitivity

Improves insulin resistance

Alpha-glucosidase inhibitors

Delays carbohydrate absorption

Reduces postprandial glucose

Meglitinides

Rapid insulin secretion

Controls post-meal glucose

Insulin

Replaces endogenous insulin

Most effective for lowering glucose

Below are some of the major anti-diabetic brands commonly prescribed in India along with their manufacturers. (Availability may vary by region and many companies also market generic versions.)

Molecule

Major Brand

Manufacturer

Metformin

Glycomet

USV Pvt. Ltd.

Cetapin

Sanofi India

Obimet

Corona Remedies

Metlong

Sun Pharmaceutical Industries

Glimepiride

Amaryl

Sanofi India

Glimisave

Eris Lifesciences

Glimy

Micro Labs

Gliclazide

Diamicron MR

Servier India

Teneligliptin

Zita

Glenmark Pharmaceuticals

Teneza

Sun Pharmaceutical Industries

Tenglyn

Mankind Pharma

Sitagliptin

Januvia

Merck Sharp & Dohme (MSD)

Istavel

Sun Pharmaceutical Industries

Vildagliptin

Galvus

Novartis India

Jalra

USV Pvt. Ltd.

Linagliptin

Trajenta

Boehringer Ingelheim

Linamac

Macleods Pharmaceuticals

Empagliflozin

Jardiance

Boehringer Ingelheim

Dapagliflozin

Forxiga

AstraZeneca

Oxra

Sun Pharmaceutical Industries

Dapasmart

Mankind Pharma

Canagliflozin

Invokana*

Johnson & Johnson (Janssen)

Pioglitazone

Pioz

USV Pvt. Ltd.

Glizone

Eris Lifesciences

Acarbose

Glucobay

Bayer

Voglibose

Volix

Sun Pharmaceutical Industries

Voglimac

Macleods Pharmaceuticals

Common Fixed-Dose Combination (FDC) Brands in India

Combination

Popular Brand

Manufacturer

Metformin + Glimepiride

Amaryl M

Sanofi India

Metformin + Glimepiride

Glimisave M

Eris Lifesciences

Metformin + Teneligliptin

Zita-Met

Glenmark Pharmaceuticals

Metformin + Sitagliptin

Janumet

Merck Sharp & Dohme (MSD)

Metformin + Vildagliptin

Galvus Met

Novartis India

Metformin + Linagliptin

Trajenta Duo

Boehringer Ingelheim

Metformin + Empagliflozin

Jardiance Duo / Synjardy

Boehringer Ingelheim

Metformin + Dapagliflozin

Xigduo XR

AstraZeneca

Metformin + Pioglitazone

Pioz MF

USV Pvt. Ltd.

Metformin + Voglibose

Volix M

Sun Pharmaceutical Industries

Top Companies in the Indian Anti-Diabetic Market

Some of the leading manufacturers in India's diabetes segment include:

  • Sun Pharmaceutical Industries
  • USV Pvt. Ltd.
  • Sanofi India
  • Eris Lifesciences
  • Glenmark Pharmaceuticals
  • Mankind Pharma
  • Micro Labs
  • Macleods Pharmaceuticals
  • Boehringer Ingelheim
  • AstraZeneca
  • Merck Sharp & Dohme (MSD)
  • Novartis India
  • Bayer

Note: Brand portfolios and marketing rights may change over time, and some multinational brands may also be marketed through local licensing arrangements in India.

Precautions and Lifestyle Changes for Type 2 Diabetes Mellitus (T2DM)

Lifestyle modification is the cornerstone of Type 2 Diabetes management. Along with medications, adopting healthy habits helps improve glycemic control, reduce complications, and enhance quality of life.


Precautions

1. Monitor Blood Glucose Regularly

  • Check fasting and postprandial blood glucose as advised.
  • Monitor HbA1c every 3–6 months.
  • Maintain a record of blood glucose readings.

Target Values (general)

  • Fasting: 80–130 mg/dL
  • 2-hour post-meal: <180 mg/dL
  • HbA1c: <7% (individualized based on age and comorbidities)

2. Take Medications as Prescribed

  • Do not skip doses.
  • Take medicines at the recommended time.
  • Never stop medication without consulting your physician.

3. Recognize Hypoglycemia (Low Blood Sugar)

Symptoms

  • Sweating
  • Trembling
  • Hunger
  • Palpitations
  • Dizziness
  • Confusion
  • Blurred vision

Immediate Management

  • Consume 15–20 g of fast-acting carbohydrate (e.g., glucose tablets, glucose powder dissolved in water, or fruit juice).
  • Recheck blood glucose after 15 minutes and repeat if necessary.

4. Prevent Hyperglycemia

Seek medical advice if blood glucose remains persistently high or if you experience:

  • Excessive thirst
  • Frequent urination
  • Fatigue
  • Blurred vision
  • Unexplained weight loss

5. Foot Care

People with diabetes are at increased risk of nerve damage and poor wound healing.

Recommendations

  • Inspect feet daily.
  • Wash and dry feet thoroughly, especially between the toes.
  • Wear comfortable, well-fitting footwear.
  • Avoid walking barefoot.
  • Seek prompt medical attention for cuts, blisters, or ulcers.

6. Eye Care

  • Have a comprehensive dilated eye examination every year to screen for diabetic retinopathy.
  • Report any sudden changes in vision promptly.

7. Kidney Care

  • Monitor kidney function and urine albumin as recommended.
  • Keep blood pressure under control.
  • Stay adequately hydrated.

8. Blood Pressure and Cholesterol Control

Maintaining healthy blood pressure and lipid levels reduces the risk of cardiovascular disease.

Typical targets (individualized):

  • Blood pressure: <130/80 mmHg (for many patients)
  • LDL cholesterol: Based on overall cardiovascular risk and physician recommendations

9. Avoid Smoking and Limit Alcohol

  • Quit smoking to reduce cardiovascular and vascular complications.
  • Limit alcohol intake and avoid drinking on an empty stomach, as it may increase the risk of hypoglycemia (particularly in people using insulin or insulin secretagogues).

Lifestyle Changes

1. Healthy Diet

Include

  • Whole grains
  • Green leafy vegetables
  • High-fiber foods
  • Legumes and pulses
  • Low-fat dairy products
  • Lean protein (fish, skinless poultry, soy, eggs)
  • Nuts and seeds (in moderation)
  • Healthy fats (olive oil, mustard oil, groundnut oil)

Limit

  • Sugary beverages
  • Sweets and desserts
  • Refined flour products
  • White bread and white rice (large portions)
  • Processed and fast foods
  • Deep-fried foods
  • Excess saturated and trans fats

2. Portion Control

  • Eat smaller, balanced meals.
  • Avoid overeating.
  • Maintain regular meal timings.
  • Avoid prolonged fasting followed by heavy meals.

3. Regular Physical Activity

Aim for:

  • At least 150 minutes/week of moderate-intensity aerobic exercise (e.g., brisk walking, cycling, swimming)
  • Resistance (strength) training 2–3 days/week
  • Flexibility and balance exercises, particularly in older adults

Physical activity:

  • Improves insulin sensitivity
  • Helps lower blood glucose
  • Supports weight management
  • Reduces cardiovascular risk

4. Weight Management

  • Even 5–10% weight loss can significantly improve insulin sensitivity and glycemic control in overweight or obese individuals.

5. Adequate Sleep

  • Aim for 7–9 hours of quality sleep per night.
  • Poor sleep can worsen insulin resistance and glucose control.

6. Stress Management

Chronic stress can increase blood glucose through stress hormones.

Helpful strategies include:

  • Meditation
  • Yoga
  • Deep breathing exercises
  • Mindfulness
  • Relaxation techniques
  • Engaging in enjoyable hobbies

7. Stay Hydrated

  • Drink sufficient water throughout the day.
  • Avoid sugar-sweetened beverages.

8. Routine Health Check-ups

Regularly monitor:

  • HbA1c
  • Blood pressure
  • Lipid profile
  • Kidney function
  • Eye health
  • Foot health
  • Dental health

Foods to Prefer vs. Foods to Limit

Prefer

Limit/Avoid

Whole grains

Sugary drinks

Green leafy vegetables

Sweets and candies

Fresh fruits (controlled portions)

Cakes, pastries, desserts

Legumes and pulses

Refined flour products

Lean protein

Deep-fried foods

High-fiber foods

Processed snacks

Nuts (moderation)

Trans fats

Healthy oils

Excess alcohol


Daily Lifestyle Checklist

✅ Take medications as prescribed
✅ Monitor blood glucose regularly
✅ Eat balanced, portion-controlled meals
✅ Exercise for at least 30 minutes on most days
✅ Stay hydrated
✅ Get adequate sleep (7–9 hours)
✅ Avoid smoking and limit alcohol
✅ Check your feet daily
✅ Attend regular medical follow-ups
✅ Manage stress effectively

Commonly Used Nutritional Supplements in Type 2 Diabetes Mellitus (T2DM)

Nutritional supplements are adjuncts to lifestyle modification and standard antidiabetic medications. They are not substitutes for prescribed glucose-lowering therapy, but selected supplements may support glycemic control, insulin sensitivity, antioxidant status, or management of diabetes-related complications when used appropriately.

Supplement

Role in Diabetes

Common Indian Brands*

Manufacturer

Alpha-Lipoic Acid

Antioxidant; supports diabetic neuropathy

Nervup OD, A to Z NS+

Mankind Pharma, Alkem Laboratories

Benfotiamine

Helps prevent and manage diabetic neuropathy

Benfomet Plus, Benalgis

Sun Pharmaceutical Industries, Intas Pharmaceuticals

Methylcobalamin

Supports nerve repair and treats B12 deficiency (common with long-term metformin use)

Nurokind, Mecobal

Mankind Pharma, P & G Health

Vitamin D3

Corrects deficiency; may support insulin sensitivity

Uprise-D3, D-Rise

Alkem Laboratories, USV Pvt. Ltd.

Magnesium

Supports insulin action in deficient individuals

Magvit, Magnical

Various manufacturers

Chromium Picolinate

May improve insulin sensitivity in selected patients

Chrominac, Chromium Picolinate capsules

Various nutraceutical companies

Omega-3 Fatty Acids

Supports cardiovascular health and triglyceride reduction

Maxepa, Omacor

Abbott, Abbott Healthcare

Coenzyme Q10

Antioxidant; supports cardiovascular and mitochondrial function

CoQ Forte, Q-Gel

Various manufacturers

Myo-Inositol

May improve insulin sensitivity in selected patients

Multiple nutraceutical brands

Various manufacturers

Probiotics

Supports gut microbiota; potential metabolic benefits

Vizylac, Darolac

USV Pvt. Ltd., Aristo Pharmaceuticals

Diabetes-Specific Nutritional Formulas

These meal replacements or diabetes nutrition formulas are commonly recommended for people with diabetes.

Brand

Manufacturer

Key Features

Ensure Diabetes Care

Abbott

High protein, low glycemic index, fiber-enriched

Prohance-D

Sun Pharmaceutical Industries

Protein-rich diabetes nutrition

Resource Diabetic

Nestlé Health Science

Low-GI formula with balanced nutrients

Diasip

Danone Nutricia

Low glycemic index, fiber-enriched

Ingredients Commonly Used in Diabetes Nutraceuticals

Many Indian nutraceutical products for diabetes contain one or more of the following:

  • Berberine
  • Cinnamon Extract
  • Fenugreek Extract
  • Gymnema sylvestre
  • Bitter Melon Extract
  • Curcumin
  • Alpha-Lipoic Acid
  • Chromium Picolinate
  • Magnesium
  • Vitamin D3
  • Methylcobalamin

Most Frequently Recommended Supplements by Clinical Scenario

Clinical Situation

Common Supplement(s)

Long-term metformin therapy

Methylcobalamin (Vitamin B12)

Diabetic neuropathy

Alpha-lipoic acid + Benfotiamine + Methylcobalamin

Vitamin D deficiency

Vitamin D3

Hypertriglyceridemia

Omega-3 fatty acids

Antioxidant support

Coenzyme Q10, Alpha-lipoic acid

Insulin resistance (selected patients)

Chromium picolinate, Magnesium (if deficient), Myo-inositol


DISCLAIMER - All details provided regarding diseases and medicines have been collated from sources in the public domain and are for general awareness purposes only. This information does not constitute medical advice. It is strongly advised not to depend on online information and to always consult a qualified Medical Doctor for a better understanding of any disease, its symptoms, and its treatment. DO NOT SELF MEDICATE under any circumstances. Medicines should only be consumed as prescribed by a registered medical practitioner; a valid prescription may be required for scheduled drugs as per applicable Indian law. GENHEALTH shall not be held responsible for any action taken based on the information provided on this platform. In case of a medical emergency, please contact your nearest hospital or dial emergency services immediately.

 2026-08-27T12:52:16

Other Pages

View all pages